1. Ukuchongwa kwesifo kunye nonyango lwe-COVID-19 (Trial version 8) yiKhomishini yezeMpilo yeSizwe ye-PRC
Umngcipheko we-thromboembolism uphezulu kwizigulana eziqatha okanye ezibaluleke kakhulu, ……, ii-Anticoagulants kufuneka zisetyenziswe ngokuchanekileyo. Kwimeko ye-thromboembolism, unyango lwe-anticoagulant kufuneka lwenziwe ngokwezikhokelo ezihambelanayo.

2. -I-CELL SARS-CoV-2 Usulelo luxhomekeke kwi-Cellular Heparan Sulfate kunye ne-ACE2, iHeparin kunye ne-non-anticoagulant derivatives block SARSCoV-2 yokubopha kunye nosulelo.

Unyango oluphela kuphela olusetyenziswa kakhulu kule ndawo luthintelo lwe-heparin yesisindo esisezantsi (LMWH), ekufuneka ithathelwe ingqalelo kuzo zonke izigulana ezibhedlele ezine-pneumonia entsha (kubandakanya abaguli abangabalulekanga) ngaphandle kokuchasana.
Isikhokelo sethutyana sokwamkelwa kunye nolawulo lwe-coagulopathy kwi-COVID-19

Kwizigulana (kubantu abadala nakwishumi elivisayo) esibhedlele esibhedlele nge-COVID-19, sebenzisa i-pharmacological prophylaxis, efana ne-heparin yesisindo esisezantsi (njenge-enoxaparin), ngokwemigangatho yasekhaya nakwamanye amazwe, ukukhusela i-venous thromboembolism, xa ingangqinelani.

Zonke izigulana ezine-COVID-19 ezinzima kwaye zibaluleke kakhulu, ziphantsi okanye ziphakathi ukuya kumngcipheko wokopha, kwaye akukho zichaso ziyacetyiswa ukuba zisebenzise iziyobisi ukukhusela i-VTE, kunye ne-heparin yesisindo esisezantsi kukukhetha kuqala; Ukungabikho ngokwaneleyo kwezintso, i-heparin engachazwanga iyacetyiswa.
Kwizigulana ezinobulali neziqhelekileyo, ukuba kukho umngcipheko ophezulu okanye ophakathi we-VTE, ukuthintelwa kweziyobisi kuyacetyiswa emva kokuba ukungqinwa kususwe, kwaye i-heparin yeemolekyuli ezisezantsi lukhetho lokuqala.

Uthintelo kunye nonyango lwe-Venous Thromboembolism ehambelana ne-Coronavirus Disease 2019 Usulelo: Isiteyitimenti sokuvumelana ngaphambi kwezikhokelo